Delivery Order SPE2DX22D0049-SPE2D826FA4BQ
- Not listed
- This delivery order, valued at $35,629.13 with an ultimate completion date of January 26, 2026, was awarded on January 23, 2026, to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. The award was made by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. This is a competitively awarded, firm fixed-price contract with no set-aside designation. The place of performance is AmerSourceBergen's corporate office location...
- This delivery order, valued at $134,528.10, was awarded on January 12, 2026, to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc., for pharmaceutical and medical supply products. The award is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The contract is performed at the awardee's corporate office location in Conshohocken, Pennsylvania, and funded by the Defense Logistics Agency's Medical...
- This delivery order, valued at $37,954.48, was awarded on January 12, 2026, to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc., for pharmaceutical and medical supply deliveries to support federal medical procurement needs. The contract is structured as a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The funding agency is the Defense Logistics Agency's Medical Supply Chain, a defense-focused organization...
- This delivery order, valued at $14,153.19, was awarded on January 19, 2026, to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc., for pharmaceutical and medical supply delivery to support federal medical procurement needs. The contract is non-set-aside and competitively awarded on a firm fixed-price basis, with an ultimate completion date of January 20, 2026. Performance will take place at the awardee's Corporate Office location in Conshohocken, Pennsylvania. This...
- This delivery order, valued at $145,629.91, was awarded on January 10, 2026, to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc., by the Defense Logistics Agency's Medical Supply Chain. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be executed at the awardee's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of January...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,447.93 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc., on February 2, 2026, with ultimate completion scheduled for February 3, 2026. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a task order executed under a...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $59,553.72 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 26, 2026, with an ultimate completion date of January 27, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under the parent entity Cencora, Inc. (doing business as AmerSourceBergen). The work will be performed at the contractor's corporate office in...
- This delivery order, valued at $1,441.95, was awarded on January 6, 2026, to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. The award is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 6, 2026, and is performed at the vendor's location in Conshohocken, Pennsylvania. The contract is funded by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for distributing medical...
- This delivery order, valued at $19,376.28, was awarded on February 2, 2026, to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc., through a firm fixed-price contract with no set-aside designation. The award is funded by the Defense Logistics Agency's Medical Supply Chain and calls for performance at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of February 3, 2026. This delivery order represents a task order under...
- This delivery order, valued at $183,604.18, was awarded on January 8, 2026, to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencara, Inc., for pharmaceutical and medical supply distribution. The contract is non-competitive and represents a task order under AmerSourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at the...
- SPE2DX22D0049Indefinite Delivery Contract
- SPE2DX22D0049-SPE2D826FA4BQDelivery Order
This delivery order, valued at $19,834.62 with a completion date of February 3, 2026, was awarded on February 2, 2026, to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc., for pharmaceutical and medical supply delivery. The contract was competitively awarded without set-aside designation and is funded by the Defense Logistics Agency's Medical Supply Chain program within the Department of Defense. AmerSourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform under a firm fixed-price structure with performance at its corporate office location in Conshohocken, PA. This delivery order represents a task order under AmerSourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs and related federal health systems worldwide. The company's demonstrated capability to fulfill diverse federal medical procurement requirements through competitive bidding underscores its strategic role in supporting Defense Health Agency operations and broader military treatment facility supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.8k | 2/1/26 |